/term/research-development/SHSE:603718 Shanghai Hile Bio-Technology Co (SHSE:603718) Research & De
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Hile Bio-Technology Co Ltd (SHSE:603718) » Definitions » Research & Development

Shanghai Hile Bio-Technology Co (SHSE:603718) Research & Development : ¥23.9 Mil (TTM As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Shanghai Hile Bio-Technology Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Shanghai Hile Bio-Technology Co's Research & Development for the three months ended in Mar. 2024 was ¥5.5 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was ¥23.9 Mil.


Shanghai Hile Bio-Technology Co Research & Development Historical Data

The historical data trend for Shanghai Hile Bio-Technology Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Hile Bio-Technology Co Research & Development Chart

Shanghai Hile Bio-Technology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 29.64 29.53 28.64 29.94 24.97

Shanghai Hile Bio-Technology Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.61 5.95 5.92 6.50 5.50

Shanghai Hile Bio-Technology Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥23.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Hile Bio-Technology Co  (SHSE:603718) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Shanghai Hile Bio-Technology Co Research & Development Related Terms

Thank you for viewing the detailed overview of Shanghai Hile Bio-Technology Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Hile Bio-Technology Co (SHSE:603718) Business Description

Traded in Other Exchanges
N/A
Address
Shanghai Jinhai Road 6720, Shanghai, CHN, 201403
Shanghai Hile Bio-Technology Co Ltd is a veterinary biological product manufacturer integrating research and development, production, sales, and service. The company has over 40 categories of poultry, livestock, and pets. The company provides services for the prevention of livestock diseases, improving the health of livestock and poultry, and improving the production efficiency of farmers, and is able to provide comprehensive solutions and an authoritative veterinary expert service system.
Executives
Zhang Lu Director
Liu Han Ping Directors, senior managers
Zhou Yu Sheng Supervisors
Zhang Hai Ming Director
Sun Guo Bao Supervisors
Zhang Yue Director
Su Bin Director
Wu Ling Yue senior management

Shanghai Hile Bio-Technology Co (SHSE:603718) Headlines

No Headlines